Results 31 to 40 of about 19,757 (178)

Is a timely assessment of the hematocrit necessary for cardiovascular magnetic resonance–derived extracellular volume measurements?

open access: yesJournal of Cardiovascular Magnetic Resonance, 2020
Background Cardiovascular magnetic resonance (CMR)–derived extracellular volume (ECV) requires a hematocrit (Hct) to correct contrast volume distributions in blood.
Mao-Yuan Su   +9 more
doaj   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

open access: yesArthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos   +2 more
wiley   +1 more source

Myocardial extracellular volume quantification with computed tomography—current status and future outlook

open access: yesInsights into Imaging, 2023
Non-invasive quantification of the extracellular volume (ECV) is a method for the evaluation of focal and diffuse myocardial fibrosis, potentially obviating the need for invasive endomyocardial biopsy.
Giulia Cundari   +4 more
doaj   +1 more source

Increased Plasma Microbial tDR‐1 in At‐Risk Individuals Is Associated With Decreased Conversion to Clinical Rheumatoid Arthritis and Reduces an In Vitro Macrophage Type 1 Interferon Response

open access: yesArthritis &Rheumatology, EarlyView.
Objective Microbial small RNAs can regulate human genes. Higher plasma concentrations of microbial transfer RNA (tRNA)‐derived RNA‐1 (tDR‐1) were previously associated with lower rheumatoid arthritis (RA) disease activity. This study examined whether tDR‐1 concentrations differ in anticyclic citrullinated peptide‐3 positive (CCP3+) at‐risk individuals (
Anastasiia Phothisane   +11 more
wiley   +1 more source

The early external cephalic version (ECV) trial: a randomised controlled trial of ECV beginning at between 34-36 weeks compared to 37-38 weeks gestation [PDF]

open access: yes, 2003
Background. In about 3–4% of all pregnancies at term the fetal presentation is non-cephalic. External cephalic version (ECV) at term has been shown to decrease the rate of non-cephalic presentation at birth, and to decrease the rate of Caesarean section (
Hutton, Eileen K. McNally
core   +1 more source

Patient characteristics by rhythm at 3 months post-ECV.

open access: yes, 2023
Patient characteristics by rhythm at 3 months post-ECV.
José M. Guerra (17027744)   +11 more
core   +1 more source

Prosocial behaviour in primary and secondary school students. Effects of the CYBUPRE intervention

open access: yesBritish Educational Research Journal, EarlyView.
Abstract Prosocial behaviour is regarded as a critical factor in reducing aggressive behaviours among peers, both in physical settings and virtual spaces. This variable facilitates the enhancement of social relationships, promoting empathy, deep listening, physical and verbal service, and even solidarity, among other benefits.
Mercedes Chicote‐Beato   +3 more
wiley   +1 more source

Establishment of a synthetic ECV model and its prognostic value in diabetes patients with acute myocardial infarction

open access: yesFrontiers in Endocrinology
BackgroundExtracellular volume (ECV) is an important marker of myocardial fibrosis. However, the prognostic role of ECV in diabetes patients is unknown. In addition, synthetic ECV without blood sampling has not been reported in diabetes cohorts.
Lei Chen   +7 more
doaj   +1 more source

Predictors of Cephalic Vaginal Delivery Following External Cephalic Version: An Eight-Year Single-Centre Study of 447 Cases

open access: yesObstetrics and Gynecology International, 2017
Introduction. Our study aims to investigate and evaluate (1) rates of success of ECV for breech presentation at term at the Royal Women’s Hospital in comparison to international standards; (2) mode of delivery following ECV; (3) factors influencing ...
Natalie Kew   +3 more
doaj   +1 more source

Glycopolymeric nanoparticles transported by activated platelets protect ischemic myocardium by alleviating PANoptosis through targeting macrophage Dectin‐1

open access: yesBMEMat, EarlyView.
NP‐SF, designed to target macrophage Dectin‐1 and activated platelets, selectively accumulated in ischemic myocardium, where it was taken up by macrophages after platelet hitchhiking. By inhibiting NLRC5‐related PANoptosis, NP‐SF significantly attenuated pathological damage, and effectively preserved cardiac function in a murine ischemia–reperfusion ...
Guanye Yu   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy